Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids

Autor: Nittoli, Thomas, Kelly, Marcus P., Delfino, Frank, Rudge, John, Kunz, Arthur, Markotan, Thomas, Spink, Jan, Chen, Zhaoyuan, Shan, Jing, Navarro, Elizabeth, Tait, Michele, Provoncha, Kathleen, Giurleo, Jason, Zhao, Feng, Jiang, Xiaobo, Hylton, Donna, Makonnen, Sosina, Hickey, Carlos, Kirshner, Jessica R., Thurston, Gavin, Papadopoulos, Nicholas

Publikováno v: In Bioorganic & Medicinal Chemistry 15 May 2018 26(9):2271-2279

The use of complementary and alternative medicine in an Irish cohort of people with an iatrogenic hepatitis C infection: Results from a health and lifestyle survey

Autor: Coughlan, Barbara M., Thornton, Lelia M., Murphy, Niamh, Tait, Michele A., Flanagan, Paula C., Kenny-Walsh, Elizabeth E., O’Lorcain, Piaras P.

Publikováno v: In Complementary Therapies in Medicine August 2014 22(4):683-689

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

Autor: Marshall, Alison D., Cunningham, Evan B., Nielsen, Stine, Aghemo, Alessio, Alho, Hannu, Backmund, Markus, Bruggmann, Philip, Dalgard, Olav, Seguin-Devaux, Carole, Flisiak, Robert, Foster, Graham R., Gheorghe, Liana, Goldberg, David, Goulis, Ioannis, Hickman, Matthew, Hoffmann, Patrick, Jancorienė, Ligita, Jarcuska, Peter, Kåberg, Martin, Kostrikis, Leondios G., Makara, Mihály, Maimets, Matti, Marinho, Rui Tato, Matičič, Mojca, Norris, Suzanne, Ólafsson, Sigurður, Øvrehus, Anne, Pawlotsky, Jean-Michel, Pocock, James, Robaeys, Geert, Roncero, Carlos, Simonova, Marieta, Sperl, Jan, Tait, Michele, Tolmane, Ieva, Tomaselli, Stefan, van der Valk, Marc, Vince, Adriana, Dore, Gregory J., Lazarus, Jeffrey V., Grebely, Jason, International Network on Hepatitis in Substance Users (INHSU)

Publikováno v: The Lancet. Gastroenterology & Hepatology
Lancet Gastroenterol Hepatol
lancet. Gastroenterology & hepatology, 3(2), 125-133. Elsevier Limited
Marshall, A D, Cunningham, E B, Nielsen, S, Aghemo, A, Alho, H, Backmund, M, Bruggmann, P, Dalgard, O, Seguin-Devaux, C, Flisiak, R, Foster, G R, Gheorghe, L, Goldberg, D, Goulis, I, Hickman, M, Hoffmann, P, Jancorienė, L, Jarcuska, P, Kåberg, M, Kostrikis, L G, Makara, M, Maimets, M, Marinho, R T, Matičič, M, Norris, S, Ólafsson, S, Øvrehus, A, Pawlotsky, J-M, Pocock, J, Robaeys, G, Roncero, C, Simonova, M, Sperl, J, Tait, M, Tolmane, I, Tomaselli, S, van der Valk, M, Vince, A, Dore, G J, Lazarus, J V, Grebely, J & International Network on Hepatitis in Substance Users (INHSU) 2018, ' Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe ', The Lancet Gastroenterology & Hepatology, vol. 3, no. 2, pp. 125-133 . https://doi.org/10.1016/S2468-1253(17)30284-4
Marshall, A D, Cunningham, E B, Nielsen, S, Aghemo, A, Alho, H, Backmund, M, Bruggmann, P, Dalgard, O, Seguin-Devaux, C, Flisiak, R, Foster, G R, Gheorghe, L, Goldberg, D, Goulis, I, Hickman, M, Hoffmann, P, Jancorienė, L, Jarcuska, P, Kåberg, M, Kostrikis, L G, Makara, M, Maimets, M, Marinho, R T, Matičič, M, Norris, S, Ólafsson, S, Øvrehus, A, Pawlotsky, J-M, Pocock, J, Robaeys, G, Roncero, C, Simonova, M, Sperl, J, Tait, M, Tolmane, I, Tomaselli, S, van der Valk, M, Vince, A, Dore, G J, Lazarus, J V, Grebely, J 2018, ' Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe ', Lancet Gastroenterology and Hepatology, vol. 3, no. 2, pp. 125–133 . https://doi.org/10.1016/S2468-1253(17)30284-4

All-oral direct-acting antiviral drugs (DAAs) for hepatitis C virus, which have response rates of 95% or more, represent a major clinical advance. However, the high list price of DAAs has led many governments to restrict their reimbursement. We revie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14bff15ad21c3e93fdf786915d0ce23a
https://doi.org/10.1016/s2468-1253(17)30284-4